Depakote sales continue to drift for Abbott as Humira rebounds
16 July 2009
Christopher Spillane
Please Login to read the full article.
16 July 2009
Christopher Spillane
christopher.spillane@informausa.com
Abbott Laboratories' second-quarter profits have slipped by 3% on a blend of charges and declining sales of Depakote (divalproex sodium). Net earnings of $1.29 billion were in line with analysts' expectations as the anti-epilepsy drug steadily lost market share to generics.
Strong sales of...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
